2023
|
Invention
|
Oncolytic viruses as adjuvants.
Herein is described oncolytic viruses for use as immunologic adj... |
2020
|
Invention
|
Oncolytic rhabdovirus.
Embodiments of the invention include compositions and methods related to ... |
|
Invention
|
Vaccine composition.
There is described a kit for use in inducing an immune response in a mammal... |
2019
|
Invention
|
Oncolytic viruses as adjuvants. Herein is described oncolytic viruses for use as immunologic adju... |
|
Invention
|
Vaccine composition. There is described a kit for use in inducing an immune response in a mammal,... |
2018
|
Invention
|
Oncolytic virus and checkpoint inhibitor combination therapy.
The present invention pertains to ... |
|
Invention
|
Compositions and methods for enhancing virus replication. Described herein is a method of enhanci... |
2017
|
Invention
|
Method of vaccination comprising a histone deacetylase inhibitor.
A vaccination method is provid... |
|
Invention
|
Oncolytic rhabdovirus expressing il12. Disclosed herein is an oncolytic recombinant Maraba virus ... |
|
Invention
|
Vaccination methods. In one aspect, a method of treating cancer in a mammal is provided. The meth... |
|
Invention
|
Pseudotyped oncolytic rhabdoviruses and their use in combination therapy.
Embodiments of the inv... |
|
Invention
|
Pseudotyped oncolytic rhabdoviruses and their use in combination therapy. Embodiments of the inve... |
|
Invention
|
Combination prime: boost therapy.
A combination prime:boost therapy is described herein. The com... |
|
Invention
|
Combination prime: boost therapy. A combination prime:boost therapy is described herein. The comb... |
|
Invention
|
Oncolytic virus and checkpoint inhibitor combination therapy. The present invention pertains to a... |
2015
|
Invention
|
Oncolytic rhabdovirus. Embodiments of the invention include compositions and methods related to M... |
2013
|
Invention
|
Oncolytic rhabdovirus. Embodiments of the invention include compositions and methods related to n... |
2012
|
Invention
|
Compositions and methods for the treatment of brain cancers.
Described herein is an isolated vir... |
|
Invention
|
Compositions and methods for the treatment of brain cancers. Described herein is an isolated vira... |
|
Invention
|
Method of vaccination comprising a histone deacetylase inhibitor. A vaccination method is provide... |
|
Invention
|
A method of vaccination comprising a histone deacetylase inhibitor. A vaccination method is provi... |
2009
|
Invention
|
Engineered synergistic oncolytic viral symbiosis. In one aspect, the invention provides methods f... |